DEXCOM INC (DXCM)

↓ Download CSV

CIK 0001093557 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, DEXCOM INC reported revenue of $4.66B, up 15.6% from the prior year. The company was profitable, with a net margin of 17.9% and a gross margin of 60.1%. It held $6.34B in total assets against $3.59B in total liabilities.

Key ratios (FY2025)

60.1%
Gross margin
19.6%
Operating margin
17.9%
Net margin
30.5%
Return on equity
+15.6%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$4.66B$4.03B$3.62B$2.91B$2.45B$1.93B$1.48B$1.03B$718.50M$573.30M
Cost of Revenue$1.86B$1.59B$1.33B$1.03B$768.00M$646.60M$544.50M$367.70M$226.40M$194.90M
Gross Profit$2.80B$2.44B$2.29B$1.88B$1.68B$1.28B$931.50M$663.90M$492.10M$378.40M
Operating Income$911.80M$600.00M$597.70M$391.20M$265.80M$299.50M$142.30M-$186.30M-$42.50M-$63.90M
Net Income$836.30M$576.20M$541.50M$341.20M$216.90M$549.70M$101.10M-$127.10M-$50.20M-$65.60M
EPS (Diluted)$2.09$1.42$1.30$0.82$0.53$1.33$1.10$-1.44$-0.58
Total Assets$6.34B$6.48B$6.26B$5.39B$4.93B$4.29B$2.40B$1.92B$904.10M$402.80M
Total Liabilities$3.59B$4.38B$4.20B$3.26B$2.89B$2.46B$1.51B$1.25B$484.70M$119.00M
Shareholders' Equity$2.75B$2.10B$2.07B$2.13B$2.04B$1.55B$882.60M$663.30M
Cash & Equivalents$917.70M$606.10M$566.30M$642.30M$1.05B$817.60M$446.20M$1.14B$441.50M$94.50M
Operating Cash Flow$1.44B$989.50M$748.50M$669.50M$442.50M$475.60M$314.50M$123.20M$92.00M$56.20M
Capital Expenditures$363.50M$358.80M$236.60M$364.80M$389.20M$199.00M$180.00M$67.10M$66.00M$55.70M
Shares Outstanding384.80M390.70M385.40M386.30M388.00M96.10M91.60M90.00M87.00M84.60M